Onglyza Class Action Lawsuit
Speak to a Lawyer in Pennsylvania to Learn If You Have a Case
Researchers have discovered that people who take Onglyza, Kombiglyze XR, or any type 2 diabetes medication containing saxagliptin or alogliptin are at a higher risk for heart failure, cardiac complications, or death. Their study showed a 27% higher chance of hospitalization for heart failure in Onglyza users—especially for people who already had a history of heart failure or kidney problems.
The findings of the study were published in August 2013, and found a higher risk of the following:
- Heart failure
- Congestive heart failure
- Cardiac complications
- Fatal cardiac event
Onglyza is produced and marketed jointly by AstraZeneca and Bristol-Meyers Squibb. It was approved for the treatment of type 2 diabetes in 2009. The drug earned over $700 million in revenue in 2012; however, in 2016 the FDA issued a warning about the increased risk of heart failure. It was official: companies had created a potentially fatal drug and sold it for widespread use.
Quick Statistics About Onglyza
- 27% increased risk of heart failure.
- 46 patient deaths reported to the FDA.
- 113 heart problems reported to the FDA.
- 1.7 million prescriptions every year.
What You Can Do Now
People who have suffered heart failure while taking Onglyza are suing AstraZeneca and Bristol-Meyers Squibb in a class-action lawsuit. If you or a loved one suffered from heart failure or heart complications while taking Onglyza or Kombiglyze XR, you may be able to join the class action, reclaim some of your losses, and hold the pharmaceutical companies accountable for your harm.
However, you’ll want to join the class action soon—there is a statute of limitations that limits how long you can wait before filing a claim against AstraZeneca or Bristol-Meyers Squibb. Statutes of limitations change depending on where you live, where you took the medication, and where/when you suffered the effects. If you wait too long to call, your case could be barred.
To find out if you’re eligible to join the class action, speak with our attorneys. Do not hesitate to call (888) 498-3023 or contact us online to set up an appointment.
About Handler, Henning & Rosenberg LLP
Since 1922, the people of Pennsylvania have relied on Handler, Henning & Rosenberg for legal help. Our team has protected the injured in more than 40,000 cases throughout the state, winning tens of millions in verdicts and settlements for the victims of harmful drugs, defective products, and more. Our meticulous investigation, love for our communities, and compassion for the injured have made us more than a lawyer to our clients—it has made us their close friends and fiercest protectors. What happened to you was wrong. We want to make it right—for your sake, and for the sake of those who care about you. Contact our firm today: (888) 498-3023
Additional Information about Onglyza & Kombiglyze XR
Nearly one-tenth of the entire American population suffers from type 2 diabetes, which is the type that is onset as an adult later in life. With adult onset diabetes, patients are prescribed a number of treatments, including some of the latest by AstraZeneca: Onglyza and Kombiglyze. These drugs have been shown to pose major health risks. All too often, patients are victimized by large pharmaceutical companies who rush FDA approval and ignore warning signs until innocent people have suffered. These drugs have been known to increase risks of fatal conditions that greatly exceed the risks of type 2 diabetes. If you or your loved one has been affected, we strongly suggest you put the more than 100 years of experience we have on your side.
Other Potential Health Hazards in These Medications
In the short amount of time that these drugs have been on the market (Onglyza in 2009 and Kombiglyze in 2010), the FDA has reported a wide range of common and harmful conditions in users.
Contact our offices if you’ve suffered the following from one of these drugs:
- Upper respiratory tract infections
- Pancreatitis (swelling of the pancreas)
- Extreme and consistent joint pain
- Pancreatic abnormalities
- Increased risk of heart attack
- Development of pre-cancerous cells
Call our Pennsylvania defective drug attorneys today at (888) 498-3023. Our award-winning attorneys have the experience, compassion, and dedication need to be successful in your case.